Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Zura Bio Limited (NASDAQ : ZURA ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.
Quote
| Last: | $6 |
|---|---|
| Change Percent: | -4.31% |
| Open: | $5.86 |
| Close: | $6.27 |
| High: | $6.1 |
| Low: | $5.86 |
| Volume: | 68,184 |
| Last Trade Date Time: | 04/02/2026 10:04:41 am |
Stock Data
| Market Cap: | $418,750,104 |
|---|---|
| Float: | 38,506,803 |
| Insiders Ownership: | 0.06% |
| Institutions: | 27 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.zurabio.com |
| Country: | KY |
| City: | Henderson |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Zura Bio Limited (NASDAQ: ZURA).
